drugset / Trial / NCT06562894
Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients
Phase 2
Not yet recruiting
156 enrolled
CSPC Ouyi Pharmaceutical Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of different doses of SYHX1901 tablets in the treatment of severe alopecia areata.
Timeline
- Start
- 2025-05-26
- Primary completion
- 2027-05-31
- Completion
- 2027-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYHX1901 | Unknown | — | Oral |